News & Articles

Only IgG assay from top four in vitro diagnostic manufacturers that detects antibodies targeting the receptor binding domain on the spike protein

More than 305,000 high-resolution, multi-channel COVID-19 cellular images are now available to the scientific community

The partnership aims to provide accessible solutions for labs involved in COVID-19 testing

Intended for use by clinical laboratories and diagnostic manufacturers, the panel aims to evaluate SARS-CoV-2 antibody assays

Key topics to include COVID-19 and infectious diseases, diabetes, sepsis, cardiovascular disease and personalized medicine as the global clinical community comes together to make the future healthier

The Oncomine Dx target test aims to identify HER2 gene mutations in non-small lung cancer patients

Clover Biopharmaceuticals initiates phase 1 study using GSK pandemic adjuvant in combination with COVID-19 vaccine candidate SCB-2019

Investment in state-of-the-art automation cements Abingdon Health’s position as a leading global rapid test manufacturer

Our new expert webinar series aims to help you get the most from your microbiology research

The company is providing well-characterized and standardized human primary cells with matching specialty cell culture media

Roche will access SpeeDx existing tests and technology to expand diagnostic products for the management of antibiotic resistance in STIs

These four viral infections have similar patient presentations, making accurate detection and differentiation critical during next flu season

Additional real-world data demonstrate meaningful outcomes for people living with diabetes who use Abbott's glucose sensing technology

The test detects antibodies made by the immune system in response to infection by the novel coronavirus in as little as 10 minutes

It's comprehensive SARS-COV-2 offerings span RT-PCR, high throughput RNA extraction, automation, ELISA and lateral flow based serology testing.

Clinical researchers are this week set to begin human trials of a new coronavirus vaccine developed by researchers at Imperial College London